Could a Parkinson's drug prevent diabetes in schizophrenia patients?
NCT ID NCT03575000
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 27 times
Summary
This small pilot study will test the safety and tolerability of bromocriptine, a drug used for other conditions, in 15 adults with schizophrenia who also have prediabetes (higher than normal blood sugar). The goal is to see if bromocriptine can help prevent or delay type 2 diabetes caused by antipsychotic medications. Participants will take bromocriptine for 6 weeks alongside their usual antipsychotic treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
VA Pittsburgh Healthcare System
Pittsburgh, Pennsylvania, 15240, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.